Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Sherman

Showing results (81-90 of 211) with videos related to

Pageof 22
Sort By:
The Journal of Infectious Diseases|April 10, 2004
Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapyJason T Blackard, Yijun Yang, Paola Bordoni, et al.
Annals of Internal Medicine|December 18, 2018
Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected RecipientsMark H Eckman, E Steve Woodle, Charuhas V Thakar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2013
Cost-effectiveness of screening for chronic hepatitis C infection in the United StatesMark H Eckman, Andrew H Talal, Stuart C Gordon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2015
Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Journal of Clinical Pathology|August 14, 2013
Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2)Mohamed Tarek M Shata, Enass A Abdel-Hameed, Helal F Hetta, et al.
Annals of Internal Medicine|July 11, 2018
Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness AnalysisMark H Eckman, E Steve Woodle, Charuhas V Thakar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2012
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 StudyAdeel A Butt, Triin Umbleja, Janet W Andersen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 2, 2016
Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Pathogens & Immunity|February 16, 2024
Replication and Injury Associated With SARS-CoV-2 in Cultured HepatocytesSuman Pradhan, Susan D Rouster, Jason T Blackard, et al.
Digestive Diseases and Sciences|September 16, 2018
PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected IndividualsKenneth E Sherman, Susan D Rouster, Minhee Kang, et al.
Pageof 22

Showing results (81-90 of 211) with videos related to

Sort By:
Pageof 22
The Journal of Infectious Diseases|April 10, 2004
Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapyJason T Blackard, Yijun Yang, Paola Bordoni, et al.
Annals of Internal Medicine|December 18, 2018
Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected RecipientsMark H Eckman, E Steve Woodle, Charuhas V Thakar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2013
Cost-effectiveness of screening for chronic hepatitis C infection in the United StatesMark H Eckman, Andrew H Talal, Stuart C Gordon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2015
Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Journal of Clinical Pathology|August 14, 2013
Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2)Mohamed Tarek M Shata, Enass A Abdel-Hameed, Helal F Hetta, et al.
Annals of Internal Medicine|July 11, 2018
Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness AnalysisMark H Eckman, E Steve Woodle, Charuhas V Thakar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2012
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 StudyAdeel A Butt, Triin Umbleja, Janet W Andersen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 2, 2016
Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Pathogens & Immunity|February 16, 2024
Replication and Injury Associated With SARS-CoV-2 in Cultured HepatocytesSuman Pradhan, Susan D Rouster, Jason T Blackard, et al.
Digestive Diseases and Sciences|September 16, 2018
PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected IndividualsKenneth E Sherman, Susan D Rouster, Minhee Kang, et al.
Pageof 22